The 70-kb plasmid pYV of Yersinia enterocolitica directs the secretion of a set of proteins, called 
Yersinia enterocolitica strains of serotypes 0:3 and 0:9 are invasive pathogens responsible for gastroenteric syndromes in humans and animals (35) . Full virulence expression of Y enterocolitica requires a plasmid 70 kb in size (12, 30, 36) . This plasmid, called pYV, encodes an original system leading to the synthesis and secretion of large amounts of proteins termed Yops (10 to 20% of total cell proteins) (6, 13, 14, 27) . This system is composed of several loci called vir, encompassing a region of about 20 kb (6) . One of these loci, virF, encodes a transcriptional regulator that activatesyop genes and some other vir loci when bacteria are incubated at 37°C (5, 20) . The large virC operon is involved in Yop secretion (26) . The synthesis and secretion of Yops are optimized when bacteria are incubated in the absence of Ca2+. However, the relationships between the bivalent cations, the expression of yop genes or vir loci, and the export process have not yet been explained. The yop genes encoding the Yops are scattered all over plasmid pYV, either alone or arranged in operons (3, 7, 29) . Several of them have been cloned and sequenced (24, 27) .
The Yop-specific secretion mechanism does not involve the removal of an N-terminal signal sequence (27) . The information required for export is nevertheless localized in the N-terminal domain (24, 27) . In the case of YopH, the first 48 amino acids of the protein are sufficient to ensure secretion. Chimeric proteins obtained by fusion of the 5'-terminal part of the yopH gene with DNA fragments encoding foreign proteins can be secreted by the Yop secretion machinery. So far, three bacterial heterologous proteins have been secreted by means of this system: the cholera toxin B subunit (33) , the alkaline phosphatase, and the a peptide of 3-galactosidase (25) .
By inserting foreign genes downstream from yop promoters, production of heterologous antigens can be obtained in laboratory animals infected with recombinant Y enterocolitica (32, 33) . Inoculation of mice with a Y enterocolitica strain expressing the cholera toxin B (CT-B) gene from the yopH promoter elicits not only a serum immunoglobulin G (IgG) and IgA response and mucosal secretory IgA production in the intestines of laboratory animals (33) but also protection against the action of the cholera toxin (34) . This immunization, which was better than that observed after inoculation of CT-B (15) . Sera of Chagas' disease patients contain antibodies directed against CRA (15, 16, 19 ). CRA appears to be specific to T. cruzi, since sera from patients infected with other parasites do not react with this antigen (15, 16, 19) .
To express CRA in Y enterocolitica, the T. cruzi gene was (17) . For inoculation of mice, the bacteria were grown as follows. A 100-,ul sample of an overnight culture grown at room temperature (RT) was inoculated in 100 ml of BHI contained in a 500-ml conical flask with four baffles and inoculated overnight with shaking (100 rpm) at room temperature. Bioluminescence measurements were done in tryptic soy broth (Gibco) (18) . The antibiotics used were ampicillin (50 or 200 p,g ml-'), gentamicin (5 or 10 p.g ml-'), kanamycin (25 p,g ml-'), nalidixic acid (35 t.g ml-'), and streptomycin (25 or 100 ,ug ml-').
Induction of theyop regulon and protein analysis. Induction of the yop regulon was done as described by Cornelis et al. (7) . Analysis of supernatant proteins and whole cell lysates by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and immunoblotting were carried out as outlined by Sory and Cornelis (32) . Monoclonal antibody 6G1 is directed against YopE (2). Purified CRA, rabbit antiserum against CRA, and human Chagas' disease serum were provided by E. Saman (Innogenetics, Ghent, Belgium).
DNA manipulations and analysis. DNA was prepared and analyzed by standard methods (22) . DNA restriction enzymes were from Pharmacia Inc. (Uppsala, Sweden), Boehringer (Mannheim, Germany), or New England Biolabs (Beverly, Mass.). The probe used to detect bacteria containing CRA by colony hybridization was the 960-bp EcoRI fragment of plasmid 7/2. The probe used to check the restriction pattern of pKNG1024 after integration of CR4 into pYV was the entire plasmid 7/2, the entire yopE-containing plasmid pMS100, or the XbaI-SalI fragment of pMSH20.
Animal infection. Animals were infected as described by Sory et al. (33) . Briefly, Y enterocolitica strains were inoculated to specific-pathogen-free 10-week-old female C57BL/6J mice (bred at the animal house of the medical faculty of the University of Louvain, Brussels, Belgium). Anti-CRA enzyme-linked immunosorbent assay (ELISA). Ninety-six-well polystyrene plates (Greiner, Nurtingen, Germany) were coated overnight at RT with CRA. Each well received 150 ng of CRA in 50 ,ul of PBS. Between steps of the assay, plates were washed three times with PBS. After saturation of the plates with 3% (wtlvol) bovine serum albumin (BSA) in PBS for 2 h at RT, serial twofold dilutions (in duplicate) in PBS-BSA of mouse plasma were added. As control sera, we used a rabbit' anti-CRA serum as well as the preimmune serum. The plates were left for 2 h at RT. Total mouse immunoglobulins against CRA were detected by incubation for 2 h at RT with specific rabbit anti-mouse horseradish peroxidase-conjugated immunoglobulins (Sigma) diluted 1,000-fold. To reveal horseradish peroxidaselabeled antibodies, 100 ,ul of a substrate solution containing 0.04% (wtlvol) o-phenylenediamine (Sigma) and 0.001% H202 in 0.1 M citrate-0.2 M phosphate buffer (pH 5.0) was added. The reaction was stopped after 3 min with 50 ,ul of 2 M H2SO4. The A492 was measured.
RESULTS
Construction of a hybrid CRA-yopE gene. The CR,4 gene was expressed in Y enterocolitica by placing the foreign DNA fragment under the control of the yop regulon. As a target, we used gene yopE, encoding the Yop protein of 25 kDa (YopE). Since we used only a partial CR4 gene (termed CR4'), the gene was directly inserted in frame within yopE (Fig. 1) . The basis for this construct was a pACYC184-derived plasmid containing the oriT site of RK2 to permit its mobilization into Y enterocolitica. Two recombinant plasmids, pMSH18 and pMSH20, were constructed (Fig. 1) . To check the hybrid yop-CRA gene, it was cloned in both orientations in pTZ18R, giving pMSH21 and pMSH22, and sequenced. In pMSH18, the hybrid gene was composed of the promoter ofyopE and of its first 506 bp (yopE') joined in frame with 941 bp of cra. pMSH20 contained the same hybrid gene followed in frame by the last 276 bp of yopE (yopE"). Production of chimeric YopE-CRA proteins in Y. enterocolitica. Plasmids pMSH18 and pMSH20 were introduced by mobilization into Y enterocolitica W22703(pYVe227). The recombinant strains were incubated in conditions of Yop production, i.e., at 37°C in a medium deprived of Ca2 . SDS-PAGE analysis ( Fig. 2 and 3) showed that Yops as well as new proteins of 65 and 80 kDa were released in the culture supernatant. Immunoblot analysis confirmed that these proteins were the hybrid YopE-CRA proteins. The proteins reacted with the anti-YopE monoclonal antibody 6G1 and with the polyclonal serum directed against CRA. No reaction of YopE with the anti-CRA serum was detected ( Fig. 2  and 3) .
Two surprising properties of the hybrid Yop-CRA proteins appeared upon analysis by SDS-PAGE and immunoblotting. First, the predicted molecular masses of the chimeric YopE'-CRA' and YopE'-CRA'-YopE" proteins were 49,994 and 57,543 kDa, respectively. The apparent molecular masses of these proteins determined by SDS-PAGE (65 and 80 kDa) were thus greater than expected. Second, immunoblot analysis revealed a set of proteins of molecular mass lower than that of the chimeric proteins. These proteins could be degradation products. They could also derive from an incomplete translation process or from truncated mRNA. Such degradation products, as well as a protein of higher molecular mass than expected, were also observed when a hybrid protein between CRA and the a peptide was expressed in E. coli (data not shown).
Integration of the hybrid yopE'-CR4'-yopE" gene into pYV. To ensure the stability of CR4 in Y enterocolitica, the hybrid yopE'-CRA'-yopE" gene encoded by pMSH20 was integrated into plasmid pYV. For this purpose, we subcloned the hybrid yopE'-CRA'-yopE" gene as an XbaI-SalI fragment in the suicide plasmid pKNG101, giving pKNG108. After transfer into strain Y enterocolitica KNG1024 (pYV1024), we checked the homologous recombination between yopE'-CRA'-yopE" of pKNG108 and yopE of pYVelO24 by Southern blot and Northern (RNA) blot (Fig.  4A) . The new plasmid was called pKNG1024. Immunoblot analysis showed that this plasmid governed secretion of the hybrid YopE'-CRA'-YopE" protein instead of YopE (Fig.  4B) .
Stability of the integration of CR4 in pKNG1024. Strain KNG1024(pKNG1024), the host strain for the yopE'-CRA'-yopE" hybrid gene, also carries the luxAB gene markers in its chromosome. In the presence of n-decanal, this strain emits light and can thus be easily detected and counted in tissues or feces of inoculated laboratory animals (18) . To evaluate the in vivo stability of our genetic construct, we inoculated one group of five C57BL/6J mice by gastric intubation with 2.1 x 1010 live bacteria of strain KNG1024(pKNG1024). Four days after inoculation, mice were sacrificed and three Peyer's patches were excised from the ileal tissue. Bioluminescence assays and plating on MacConkey agar indicated that 9.7 x 103 to 1.3 x 105 bacteria were present per Peyer's patch. The stability of CRA in pYV1024 in these bacteria was monitored. Forty-six to forty-eight colonies per mouse were tested by replica plating and colony hybridization with a CRA probe. All of the 238 bacteria isolated from mice that received KNG1024(pKNG1024) still contained the CRA gene. Hence, the construct is stable in vivo. This finding is in contrast with results obtained with a pACYC184-derived plasmid expressing CRA. This plasmid was easily lost 3 days after inoculation. In five mice that received W22703 (pYVe227)(pMSH20), only 15, 23, 31, 48 , and 98% of bacteria isolated from the Peyer's patches still contained pMSH20. Immunization of mice with a CRA-producing strain. We then examined whether gastric inoculation of mice with the recombinant Y enterocolitica strain would elicit an immune response against CRA. We first monitored colonization of the intestinal lumen of mice by the strain producing YopE-CRA and by the parental strain by measuring the quantity of bacteria excreted in the feces. Two groups of 10 C57BL/6J mice were inoculated with either 1.4 x 10°bacteria of strain KNG1024(pYV1024) or 2.1 x 1010 bacteria of strain KNG1024(pKNG1024). At days 6 and 11, feces were taken from five mice and tested by luminometry. At day 6, we detected 7.7 x 103 to 4.6 x 104 bacteria per mg of stools isolated from mice that received KNG1024(pKNG1024). In the same time, we detected 1.1 x 104 to 8.5 x 104 bacteria per mg of stools isolated from mice that received KNG1024(pYV1024). No bacteria could be detected by luminometry 11 days after the inoculation. At day 14, mice were inoculated again with 1.1 x 1010 or 1.6 x 1010 bacteria of strain KNG1024(pYV1024) or KNG1024(pKNG1024), respectively, and tested for the presence of bacteria in the intestinal lumen. Only a few bacteria (about 102/mg of feces) in a limited number of mice (one or two mice) were detected 4 days after the inoculation. There was no significant difference in the colonization capacity of the strain carrying pKNG1024 or the wild-type pYV1024 plasmid.
We then studied the antibody response to CRA in these mice. Plasma samples were collected 12 days after the first inoculation and 11 days after the second inoculation. Analysis by anti-CRA ELISA (Fig. 5) eukaryotic protein has been found to be produced and secreted by Y enterocolitica. This bacterium, like Bacillus subtilis, could thus be used to secrete biotechnologically important proteins. Indeed, Y enterocolitica grows easily and has a specific and powerful secretion system. These two properties are relevant to the use of this bacterium as an in vitro producer of recombinant proteins. Its pathogenic capacity is now quite well understood and could easily be disarmed. The chromosome gene encoding the enterotoxin Yst (9) should be removed, and the virulence could be decreased by removing one or the other yop gene or eventuallyyadA (for a recent review, see reference 8).
In this study, the CRA protein was produced as a hybrid Yop-CRA protein. When live recombinant bacteria were given by gastric intubation to mice, a good antibody response was obtained, confirming that Y enterocolitica can be used to deliver heterologous proteins to the immune system. In this work, we studied only the serum antibody response. However, the production of hybrid Yop-CRA proteins could be used to analyze the serum, secretory, and cell-mediated immune responses elicited by hybrid proteins secreted during infection by recombinant Y enterocolitica.
To stabilize the production of CRA, we integrated the fusion gene in plasmid pYV itself. Integration into pYV by a double-homologous recombination allowed maximal stability of the construction. Indeed, all bacteria isolated from the intestinal tissue 4 days after inoculation still harbored the CRA gene.
Production of the hybrid YopE'-CRA'-YopE" in Y enterocolitica resulted in a decrease in Yop production. Since the number of copies of CRA is the same as that of the other yop genes, the decrease in Yop production could not result from the titration of VirF or some other transcriptional regulator. One could speculate that it results from titration of the secretion factors by the hybrid protein.
